Mutagenesis Advance Access originally published online on February 17, 2008
Mutagenesis 2008 23(3):143-151; doi:10.1093/mutage/gem051
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
The comet assay: topical issues
t
tina71Department of Nutrition, Faculty of Medicine, University of Oslo, Oslo, Norway 2Norwegian Institute of Public Health, Oslo, Norway 3Genetic and Biotechnology Department, University of Trás-os-Montes and Alto Douro, Quinta de Prados, Vila Real, Portugal 4Department of Preclinical and Clinical Pharmacology, University of Florence, Florence, Italy 5Institute of Nuclear Chemistry and Technology, Warszawa, Poland 6AstraZeneca, Safety Assessment, R&D, Macclesfield, UK 7Faculty of Military Health Sciences, University of Defence, Hradec Kralove, Czech Republic
The comet assay is a versatile and sensitive method for measuring single- and double-strand breaks in DNA. The mechanism of formation of comets (under neutral or alkaline conditions) is best understood by analogy with nucleoids, in which relaxation of DNA supercoiling in a structural loop of DNA by a single DNA break releases that loop to extend into a halo—or, in the case of the comet assay, to be pulled towards the anode under the electrophoretic field. A consideration of the simple physics underlying electrophoresis leads to a better understanding of the assay. The sensitivity of the assay is only fully appreciated when it is calibrated: between one hundred and several thousand breaks per cell can be determined. By including lesion-specific enzymes in the assay, its range and sensitivity are greatly increased, but it is important to bear in mind that their specificity is not absolute. Different approaches to quantitation of the comet assay are discussed. Arguments are presented against trying to apply the comet assay to the study of apoptosis. Finally, some of the advantages and disadvantages of using the comet assay on lymphocyte samples collected in human studies are rehearsed.
* To whom correspondence should be addressed at Department of Nutrition, Faculty of Medicine, University of Oslo, PB 1046 Blindern, 0316 Oslo, Norway. Tel: +47 22851360; Fax: +47 22851341; Email: a.r.collins{at}medisin.uio.no
Received on October 10, 2007; revised on November 28, 2007; accepted on December 6, 2007.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
L. Forchhammer, C. Johansson, S. Loft, L. Moller, R. W. L. Godschalk, S. A. S. Langie, G. D. D. Jones, R. W. L. Kwok, A. R. Collins, A. Azqueta, et al. Variation in the measurement of DNA damage by comet assay measured by the ECVAG inter-laboratory validation trial Mutagenesis, November 12, 2009; (2009) gep048v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. de Oliveira, A. G. dos Santos, R. A. dos Santos, A. R. Csipak, C. Olivato, I. C. da Silva, M. B. de Freitas, C. L. Bassi, A. J. Cavalheiro, V. S. Bolzani, et al. Ethanolic extract of Casearia sylvestris and its clerodane diterpen (caseargrewiin F) protect against DNA damage at low concentrations and cause DNA damage at high concentrations in mice's blood cells Mutagenesis, November 1, 2009; 24(6): 501 - 506. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zainol, J. Stoute, G. M. Almeida, A. Rapp, K. J. Bowman, G. D. D. Jones, and ECVAG Introducing a true internal standard for the Comet assay to minimize intra- and inter-experiment variability in measures of DNA damage and repair Nucleic Acids Res., October 14, 2009; (2009) gkp826v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Milkovic, V. Garaj-Vrhovac, M. Ranogajec-Komor, S. Miljanic, G. Gajski, Z. Knezevic, and N. Beck Primary DNA Damage Assessed With the Comet Assay and Comparison to the Absorbed Dose of Diagnostic X-rays in Children International Journal of Toxicology, September 1, 2009; 28(5): 405 - 416. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Herrera, G. Dominguez, J. M. Garcia, C. Pena, C. Jimenez, J. Silva, V. Garcia, I. Gomez, R. Diaz, P. Martin, et al. Differences in Repair of DNA Cross-links between Lymphocytes and Epithelial Tumor Cells from Colon Cancer Patients Measured In vitro with the Comet Assay Clin. Cancer Res., September 1, 2009; 15(17): 5466 - 5472. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Grigaravicius, A. Rapp, and K. O. Greulich A direct view by immunofluorescent comet assay (IFCA) of DNA damage induced by nicking and cutting enzymes, ionizing 137Cs radiation, UV-A laser microbeam irradiation and the radiomimetic drug bleomycin Mutagenesis, March 1, 2009; 24(2): 191 - 197. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Wu, J. B. Wilson, A. M. Wolfreys, A. Scott, and N. J. Jones Optimization of the comet assay for the sensitive detection of PUVA-induced DNA interstrand cross-links Mutagenesis, March 1, 2009; 24(2): 173 - 181. [Abstract] [Full Text] [PDF] |
||||



